Radhakrishnan 1983.
Study characteristics | |||
Patient sampling | Prospecitve, consecutive. | ||
Patient characteristics and setting |
N included in study: 266. N in analysis: 266. Age: Not reported. Gender: Not reported. Ethnicity: Not reported. Comorbid disorders: Not reported. Duration of symptoms: Not reported. Concurrent medications used: Not reported. Inclusion criteria: All admissions over a period of 18 months. Exclusion criteria: Not reported. Study aim: To evaluate the prevalence of FRS and their diagnostic and prognostic implications. Previous treatment for schizophrenia: Not reported. Clinical setting: Inpatients. Country: India. |
||
Index tests |
Description of FRS used: Questions to establish the presence of FRS were asked according to the standardised interview schedule of the International Pilot Study of Schizophrenia. The patients were interviewed before starting on any medication. The first rank symptoms were rated as either present, or absent. Professionals performing test: Not reported. Resolution of discrepancies: Not reported. How FRS used in study: Prevalence, diagnosis, prognosis. |
||
Target condition and reference standard(s) |
Reference standard: Diagnostic criteria used were according to the International Classification of Diseases: lCD 9. Only those patients who satisfied the criteria of Feighner for schizophrenia were included in the schizophrenia group. Target condition(s): Schizophrenia, affective disorders, hysterical psychosis, paranoid state, acute psychotic reaction, organic psychosis, neurotic disorders, personality disorders, and temporal lobe epilepsy. Professionals performing test: Not reported. Resolution of discrepancies: Not reported. |
||
Flow and timing |
Study process: Not reported when patients were diagnosed and interviewed for FRS. Follow‐up: Not reported. Exclusion: Exclusions not explicitly reported. All participants received a diagnosis according to the reference standard, unclear whether all were evaluated for FRS. |
||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Unclear | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Unclear | High | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
Did the study pre‐specify whether they were using one or multiple FRSs? | No | ||
Unclear | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Unclear | Unclear | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Were all patients included in the analysis? | Yes | ||
Did all patients receive a reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Did all patients receive an index test? | Yes | ||
Did all patients receive the same index test? | Yes | ||
Low |